Fitzal, Florian
Bolliger, Michael
Dunkler, Daniela
Geroldinger, Angelika
Gambone, Luca
Heil, Jörg
Riedel, Fabian
de Boniface, Jana
Andre, Camilla
Matrai, Zoltan
Pukancsik, Dávid
Paulinelli, Regis R.
Ostapenko, Valerijus
Burneckis, Arvydas
Ostapenko, Andrej
Ostapenko, Edvin
Meani, Francesco
Harder, Yves
Bonollo, Marta
Alberti, Andrea S. M.
Tausch, Christoph
Papassotiropoulos, Bärbel
Helfgott, Ruth
Heck, Dietmar
Fehrer, Hans-Jörg
Acko, Markus
Schrenk, Peter
Trapp, Elisabeth K.
Gunda, Pristauz-Telsnigg
Clara, Paliczek
Montagna, Giacomo
Ritter, Mathilde
Blohmer, Jens-Uwe
Steffen, Sander
Romics, Laszlo
Morrow, Elizabeth
Lorenz, Katharina
Fehr, Mathias
Weber, Walter Paul
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 10 May 2021
Accepted: 3 September 2021
First Online: 13 October 2021
Declarations
:
: F. Fitzal received personal honoraria and educational grants from Pfizer, Novartis, Roche, Astra Zeneca, Springer, Medtronic, and Bondimed. W. P.Weber has received research support from Takeda Pharmaceuticals International via Swiss Group for Clinical Cancer Research (SAKK), honoraria/consultation from Genomic Health, Inc., USA, and support paid to the University Hospital Basel for conferences and meetings from Sandoz, Genomic Health, Medtronic, Novartis Oncology, Pfizer, and Eli Lilly. No other authors have conflict of interest disclosures to report.
: F. Fitzal had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
: This study was presented in poster format at the 17<sup>th</sup> St. Gallen International Breast Cancer Conference 2021 (virtual meeting) as well as at the annual congress of the Austrian Society of Surgery 2021, virtual meeting.